Cargando…
Cardiovascular Disease in Systemic Lupus Erythematosus
There is a well-known increased risk for cardiovascular disease that contributes to morbidity and mortality in systemic lupus erythematosus (SLE). Major adverse cardiovascular events and subclinical atherosclerosis are both increased in this patient population. While traditional cardiac risk factors...
Autores principales: | McMahon, Maureen, Seto, Richard, Skaggs, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242526/ https://www.ncbi.nlm.nih.gov/pubmed/35880242 http://dx.doi.org/10.2478/rir-2021-0022 |
Ejemplares similares
-
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
por: Hahn, Bevra H, et al.
Publicado: (2008) -
A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus
por: Skaggs, Brian J., et al.
Publicado: (2021) -
Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
por: Zhu, Lisa, et al.
Publicado: (2022) -
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis
por: Bello, Natalia, et al.
Publicado: (2022) -
Systemic lupus erythematosus and cardiovascular disease
por: Frostegård, Johan
Publicado: (2022)